These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27941535)

  • 21. Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus.
    Xu LY; Jiao Z; Liu FY; Qiu XY; Ji L; Zhang M
    Ther Drug Monit; 2018 Oct; 40(5):572-580. PubMed ID: 29847459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney transplant recipients at a single institute in China.
    Xu L; Cai M; Shi BY; Li ZL; Li X; Jin HL
    Transplant Proc; 2014 Jun; 46(5):1362-5. PubMed ID: 24935300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.
    Tedesco-Silva H; Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Slade A; Schmouder R; Medina-Pestana JO
    Clin Transplant; 2010; 24(4):E116-23. PubMed ID: 20047618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus.
    Sánchez Fructuoso AI; Perez-Flores I; Calvo N; Valero R; Matilla E; Ortega D; Del Dedo MA; Fernández-Pérez C; Barrientos A
    Ther Drug Monit; 2012 Jun; 34(3):298-305. PubMed ID: 22549501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
    Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
    Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Multiple Linear Regression-Based Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients.
    Brooks EK; Tett SE; Isbel NM; McWhinney B; Staatz CE
    Ther Drug Monit; 2018 Apr; 40(2):195-201. PubMed ID: 29461443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients.
    Hao C; Erzheng C; Anwei M; Zhicheng Y; Baiyong S; Xiaxing D; Weixia Z; Chenghong P; Hongwei L
    Liver Transpl; 2007 Dec; 13(12):1684-93. PubMed ID: 18044788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.
    Yamaguchi K; Fukuoka N; Kimura S; Watanabe M; Tani K; Tanaka H; Sofue T; Kosaka S; Inui M; Kakehi Y; Houchi H
    Biol Pharm Bull; 2013; 36(6):1036-9. PubMed ID: 23558676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
    Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
    Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an Abbreviated Mycophenolic Acid Area Under the Time-Concentration Curve for Renal Transplant Patients Under Enteric-Coated Mycophenolate Sodium: A Comparison With Critical Analysis of Available Equations.
    David-Neto E; Triboni AH; Ramos F; Agena F; Romano P
    Ther Drug Monit; 2018 Aug; 40(4):411-416. PubMed ID: 29746396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.
    Sobiak J; Resztak M; Głyda M; Szczepaniak P; Chrzanowska M
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):331-8. PubMed ID: 25663618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.
    Chen H; Peng C; Yu Z; Shen B; Deng X; Qiu W; Fei Y; Shen C; Zhou G; Yang W; Li H
    Clin Pharmacokinet; 2007; 46(2):175-85. PubMed ID: 17253887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the practicability of limited sampling strategies for the estimation of mycophenolic acid exposure in Chinese adult renal recipients.
    Zicheng Y; Xianghui W; Peijun Z; Da X; Weixia Z; Hongzhuan C
    Ther Drug Monit; 2007 Oct; 29(5):600-6. PubMed ID: 17898650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus.
    Djabarouti S; Duffau P; Lazaro E; Chapouly C; Greib C; Viallard JF; Pellegrin JL; Saux MC; Breilh D
    Expert Opin Pharmacother; 2010 Apr; 11(5):689-99. PubMed ID: 20210680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity.
    Shah T; Tellez-Corrales E; Yang JW; Qazi Y; Wang J; Wilson J; Hutchinson I; Min DI
    Ther Drug Monit; 2011 Feb; 33(1):45-9. PubMed ID: 21099740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients.
    Kamar N; Rostaing L; Cassuto E; Villemain F; Moal MC; Ladrière M; Barrou B; Ducloux D; Chaouche K; Quéré S; Di Giambattista F; Be F
    Clin Nephrol; 2012 Feb; 77(2):126-36. PubMed ID: 22257543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
    Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
    Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.